Autobio Diagnostics Co., Ltd. (SHA:603658)

Autobio Diagnostics Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	4,241	4,389	4,368	4,366	3,686	2,898
Other Revenue	83.87	81.98	76.05	75.76	79.82	80.1
Revenue	4,324	4,471	4,444	4,442	3,766	2,978
Revenue Growth (YoY)	-4.81%	0.62%	0.05%	17.94%	26.45%	11.15%
Cost of Revenue	1,567	1,582	1,612	1,844	1,545	1,216
Gross Profit	2,758	2,889	2,832	2,597	2,221	1,762
Selling, General & Admin	984.16	953.05	920.21	857.11	757.02	589.91
Research & Development	649.05	731.93	656.13	568.48	480.96	342.8
Other Operating Expenses	33.77	-3.25	28.05	28.24	13.73	22.75
Operating Expenses	1,706	1,737	1,626	1,471	1,267	981.61
Operating Income	1,052	1,152	1,206	1,126	954.28	780.48
Interest Expense	-20.17	-22.28	-24.54	-21.23	-12.68	-29.05
Interest & Investment Income	135.17	112.84	144.76	135.09	116.43	61.8
Currency Exchange Gain (Loss)	5.31	0.63	1.19	7.47	-9.65	-2.76
Other Non Operating Income (Expenses)	0.25	-2.08	-2.9	-5.18	0.77	-15.78
EBT Excluding Unusual Items	1,172	1,241	1,325	1,242	1,049	794.69
Gain (Loss) on Sale of Investments	-3.48	3.61	0.58	-	0.03	0.09
Gain (Loss) on Sale of Assets	-11.99	-12.2	-2.78	-1.72	-1.17	-1.13
Asset Writedown	-43.98	-52.75	-	-	-	-
Other Unusual Items	127.68	109.07	39.95	53.06	17.54	50.88
Pretax Income	1,241	1,289	1,363	1,294	1,066	844.53
Income Tax Expense	90.42	89.82	138.41	105.03	85.69	87.44
Earnings From Continuing Operations	1,150	1,199	1,224	1,189	979.86	757.09
Minority Interest in Earnings	-4.35	-4.78	-6.69	-21.25	-6.19	-9.3
Net Income	1,146	1,194	1,217	1,167	973.66	747.79
Net Income to Common	1,146	1,194	1,217	1,167	973.66	747.79
Net Income Growth	-11.24%	-1.89%	4.28%	19.90%	30.20%	-3.41%
Shares Outstanding (Basic)	573	577	580	584	587	558
Shares Outstanding (Diluted)	573	577	580	584	587	558
Shares Change (YoY)	-0.14%	-0.47%	-0.68%	-0.48%	5.10%	2.03%
EPS (Basic)	2.00	2.07	2.10	2.00	1.66	1.34
EPS (Diluted)	2.00	2.07	2.10	2.00	1.66	1.34
EPS Growth	-11.12%	-1.43%	5.00%	20.48%	23.88%	-5.33%
Free Cash Flow	615.81	644.88	569.44	620.1	395.39	-120.67
Free Cash Flow Per Share	1.07	1.12	0.98	1.06	0.67	-0.22
Dividend Per Share	1.260	1.260	1.052	0.800	0.750	0.654
Dividend Growth	19.76%	19.76%	31.51%	6.67%	14.71%	-5.56%
Gross Margin	63.77%	64.61%	63.73%	58.47%	58.98%	59.17%
Operating Margin	24.33%	25.77%	27.15%	25.36%	25.34%	26.21%
Profit Margin	26.50%	26.71%	27.40%	26.28%	25.86%	25.11%
Free Cash Flow Margin	14.24%	14.42%	12.81%	13.96%	10.50%	-4.05%
EBITDA	1,520	1,616	1,642	1,544	1,340	1,082
EBITDA Margin	35.14%	36.15%	36.96%	34.76%	35.59%	36.33%
D&A For EBITDA	467.74	464.2	436.1	417.56	385.93	301.56
EBIT	1,052	1,152	1,206	1,126	954.28	780.48
EBIT Margin	24.33%	25.77%	27.15%	25.36%	25.34%	26.21%
Effective Tax Rate	7.29%	6.97%	10.16%	8.12%	8.04%	10.35%
Revenue as Reported	4,324	4,471	4,444	4,442	3,766	2,978
Advertising Expenses	-	54.35	55.79	41.4	45.1	32.03

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.